Afficher la couverture 'Baclofen for the treatment of alcohol use disorder: the cagliari statement | Agabio, Roberta' en grand format
/5

0 avis

Baclofen for the treatment of alcohol use disorder: the cagliari statement

Archive ouverte

Agabio, Roberta | Sinclair, Julia M. A. | Addolorato, Giovanni | Aubin, Henri-Jean | Beraha, Esther M. | Caputo, Fabio | Chick, Jonathan D. | de la Selle, Patrick | Franchitto, Nicolas | Garbutt, James C. | Haber, Paul S. | Heydtman, Mathis | Jaury, Philippe | Lingford-Hughes, Anne R. | Morley, Kirsten C. | Muller, Christian A. | Owens, Lynn | Pastor, Adam | Paterson, Louise M. | Pelissier, Fanny | Rolland, Benjamin | Stafford, Amanda | Thompson, Andrew | van den Brink, Wim | de Beaurepaire, Renaud | Leggio, Lorenzo

Edité par CCSD ; Elsevier -

International audience. lcohol use disorder is a leading cause of morbidity and mortality.1–2 Alcohol consumption is related to approximately 4% of the global burden of disease.1 In clinical settings and compared with the general population, the relative risk of mortality has been estimated to be 3·38 for male patients and 4·57 for female patients with alcohol use disorder.2 Patients who reduce their alcohol consumption can halve this increased risk of mortality compared with patients with alcohol use disorder who do not.3 However, the approved pharmacotherapies that could help patients with alcohol use disorder to achieve abstinence or reduce alcohol consumption are limited in number and efficacy.4–5 Therefore, there is an urgent need to develop more effective treatments in this area.

Consulter en ligne

Suggestions

Du même auteur

The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective

Archive ouverte | de Beaurepaire, Renaud | CCSD

International audience. Alcohol use disorder (AUD) is a brain disorder associated with high rates of mortality and morbidity worldwide. Baclofen, a selective gamma-aminobutyric acid-B (GABA-B) receptor agonist, has ...

Baseline severity and the prediction of placebo response in clinical trials for alcohol dependence: A meta‐regression analysis to develop an enrichment strategy

Archive ouverte | Scherrer, Bruno | CCSD

International audience. Background: There is considerable unexplained variability in alcohol abstinence rates (AR) in the placebo groups of randomized controlled trials (RCTs) for alcohol dependence (AD). This is of...

Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial

Archive ouverte | Guiraud, Julien | CCSD

International audience. Background: Sodium oxybate (SMO) has been shown to be effective in the maintenance of abstinence (MoA) in alcohol-dependent patients in a series of small randomized controlled trials (RCTs). ...

Chargement des enrichissements...